Page last updated: 2024-08-16

sdz 205-557 and n-methyl-3,4-methylenedioxyamphetamine

sdz 205-557 has been researched along with n-methyl-3,4-methylenedioxyamphetamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gudelsky, GA; Nair, SG	1

Other Studies

1 other study(ies) available for sdz 205-557 and n-methyl-3,4-methylenedioxyamphetamine

Article	Year
3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex. Synapse (New York, N.Y.), 2005, Dec-15, Volume: 58, Issue:4 Topics: 4-Aminobenzoic Acid; Acetylcholine; Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Hallucinogens; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; para-Aminobenzoates; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin, 5-HT4; Serotonin Antagonists	2005

Article

Year

3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.

Synapse (New York, N.Y.), 2005, Dec-15, Volume: 58, Issue:4

Topics: 4-Aminobenzoic Acid; Acetylcholine; Animals; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Hallucinogens; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; para-Aminobenzoates; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Serotonin, 5-HT4; Serotonin Antagonists

2005